Background: Diarrhea, a common complication after solid organ transplant (SOT), is
| INTRODUCTION
Diarrhea is a frequent complication after solid organ transplant (SOT) and can lead to alterations in immunosuppressive therapy, hospitalizations, allograft failure, and mortality. [1] [2] [3] In community-onset diarrhea, most episodes are from non-infectious etiologies, including immunosuppressive therapy, and only 20%-40% are related to infections.
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Clostridium difficile, norovirus (NV), and cytomegalovirus (CMV) are the most common causes of infectious diarrhea, while opportunistic and parasitic infections occur infrequently. [3] [4] [5] [6] Most episodes of posttransplant diarrhea, regardless of the cause, ultimately resolve.
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No evidence-based guidelines are available for the evaluation of diarrhea in SOT recipients. Expert recommendations include stepwise 3,4 and simultaneous 7-10 testing approaches, but it is unclear how these strategies compare in terms of accuracy, timing, and costs. Many testing approaches recommend diagnostics directed at the most common causes of infectious diarrhea including NV. 3, 6, 10 It is unknown if NV testing is a worthwhile use of resources, as no specific treatment exists beyond providing supportive care and reducing immunosuppressive therapy. However, confirming an NV diagnosis may lead to indirect cost savings by informing infection control measures, reducing length of hospital stay, and preventing additional diagnostic evaluation including endoscopy.
We performed a cost analysis on a previously described retrospective cohort to derive a testing algorithm for the evaluation of community-onset diarrhea in SOT recipients. 5 We hypothesized a stepwise testing strategy would reduce costs without compromising diagnostic yields.
| MATERIALS AND METHODS
A cost analysis was performed on a retrospective cohort of SOT recipients admitted with community-onset diarrhea from March 1, 2012 through September 30, 2013 to Northwestern Memorial Hospital, Chicago, IL, USA. 5 Patient identification methods and inclusion and exclusion criteria were previously described. were "diagnosis of infectious diarrhea" and "no diagnosis of infectious diarrhea." Test outcomes included the results for all diagnostic tests performed during the step. The analyses were performed using testing rates and diagnostic yields from the original cohort.
For each step in the model, the false-omission rate (FOR) was calculated to assess the contribution of each test to the diagnostic yield. The FOR was defined as "false-negative tests" divided by the sum of "false-negative tests" and "true-negative tests." Falsenegative tests were equivalent to missed diagnoses of infectious diarrhea-diagnoses not identified by the tests in each step. By definition, the FOR would decrease as tests were added to each step of the model. We compared tests by calculating test cost per decrease in FOR.
A secondary time-to-event analysis was conducted to assess if NV testing led to indirect cost savings by decreasing the length of hospital stay. Patients who had testing for CMV, C. difficile, and/or NV were included (n=389) in the analysis. Time to discharge was compared between those who had stool NV PCR testing to those who did not. The non-parametric Wilcoxon test of equality of the survival functions was used with an alpha of 0.05 to reject the null hypothesis of both groups being equal.
| RESULTS
A total of 422 admissions for community-onset diarrhea (314 unique patients) were identified. Demographic and clinical characteristics were previously described. 5 Onset of diarrhea occurred a median 1028 days after transplant (interquartile range 240-2372 days).
Transplant types included kidney (42.7%), liver (24.6%), heart (11.1%), pancreas (2.6%), bowel (0.7%), pancreas-kidney (9.0%), and liver- The denominator for percentage is the total number of admissions for community-acquired diarrhea (n=422).
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The denominator for percentage is the total number of tests performed (presented in the second column). PCR, polymerase chain reaction, CMV, cytomegalovirus; qPCR, quantitative PCR; EIA, enzyme immunoassay; O&P, ova and parasites test.
| DISCUSSION
Diarrhea is a frequent occurrence in SOT recipients, but infections are responsible for only 20%-40% of episodes. [3] [4] [5] [6] The majority of infectious episodes can be attributed to a few clinically indistinguishable pathogens. achieve a cost savings of $48 420 (51% of total cost) with an FOR of 4%-a reasonable FOR, as NV accounts for 90% of missed diagnoses.
A major limitation to our testing strategy is its reliance on molecular diagnostics. The testing strategy may result in over-diagnosis and, as a result, over-treatment of C. difficile, as it relies exclusively on molecular testing without considering toxin production and host immune response. 11 Additional studies are needed to assess testing strategies in SOT recipients including both C. difficile PCR and toxin immunoassay. Furthermore, the possibility of missing diagnoses of CMV gastrointestinal disease exists, because plasma CMV qPCR has a sensitivity of 85%. 12 In our cohort, two patients with CMV colitis had a negative qPCR on initial evaluation (2/26, 7.7%). A negative plasma CMV qPCR
should not exclude CMV gastrointestinal disease and we recommend endoscopy in the second-stage evaluation of persistent episodes.
Multiplex PCR assays for gastrointestinal pathogens have several advantages including high sensitivity, rapid turnaround time, and potentially lower costs with consolidated laboratory testing and workflow. 13 However, exclusive reliance on molecular diagnostics without considering the clinical presentation and immune response may lead to over-diagnosis and over-treatment. Practice guidelines indicate that patient-specific epidemiologic history should provide the foremost guidance for the evaluation of diarrhea. 14 We feel that our proposed strategy may serve as a general starting point for the evaluation of community-onset diarrhea in SOT recipients where no clear etiology is suggested by the epidemiological history. Thus, whereas a specific history and epidemiologic exposure should prompt consideration for individualized testing, a history of SOT does not necessarily denote a need for extensive first-line testing beyond that proposed in this study.
| CONCLUSIONS
In SOT recipients admitted with community-onset diarrhea, a stepwise testing strategy reduces costs without compromising diagnostic yields.
The cost analysis suggests initial evaluation should be directed to the most frequently encountered infectious etiologies: C. difficile, CMV, NV, and food-borne bacterial pathogens. This testing strategy captures the vast majority of infectious episodes and rarely misses a diagnosis.
However, we recommend a strategy that reserves stool NV testing to 
